Copyright
©The Author(s) 2023.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2138-2149
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2138
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2138
Table 1 Patient characteristics
| Patient characteristics | n | |
| Age (yr) | < 60 | 14 |
| ≥ 60 | 6 | |
| Gender | Male | 12 |
| Female | 8 | |
| Pathologic stage | Stage I | 4 |
| Stage II | 12 | |
| Stage III | 4 | |
- Citation: Zhang XS, Zhou HC, Wei P, Chen L, Ma WH, Ding L, Liang SC, Chen BD. Combined TIM-3 and PD-1 blockade restrains hepatocellular carcinoma development by facilitating CD4+ and CD8+ T cell-mediated antitumor immune responses. World J Gastrointest Oncol 2023; 15(12): 2138-2149
- URL: https://www.wjgnet.com/1948-5204/full/v15/i12/2138.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v15.i12.2138